Mitsopoulos Costas, Zihni Ceniz, Garg Ritu, Ridley Anne J, Morris Jonathan D H
Department of Academic Surgery, GKT School of Medicine and Dentistry, Rayne Institute, 123 Coldharbour Lane, London SE5 9NU, United Kingdom.
J Biol Chem. 2003 May 16;278(20):18085-91. doi: 10.1074/jbc.M213064200. Epub 2003 Mar 13.
Sterile 20 (STE20) protein kinases, which include germinal center kinases and p21-activated protein kinases, are known to activate mitogen-activated protein kinase pathways (c-Jun NH(2)-terminal kinase, p38, or extracellular signal-regulated kinase), leading to changes in gene transcription. Some STE20s can also regulate the cytoskeleton, and we have shown that the germinal center kinase-like kinase prostate-derived STE20-like kinase (PSK) affects actin cytoskeletal organization. Here, we demonstrate that PSK colocalizes with microtubules; and that this localization is disrupted by the microtubule depolymerizing agent nocodazole. The association of PSK with microtubules results in the production of stabilized perinuclear microtubule cables that are nocodazole-resistant and contain increased levels of acetylated alpha-tubulin. Kinase-defective PSK (K57A) or the C terminus of PSK (amino acids 745-1235) lacking the kinase domain are sufficient for microtubule binding and stabilization, demonstrating that the catalytic activity of the protein is not required. The localization of PSK to microtubules occurs via its C terminus, and PSK binds and phosphorylates alpha- and beta-tubulin in vitro. The N terminus of PSK (1-940) is unable to bind or stabilize microtubules, demonstrating that PSK must associate with microtubules for their reorganization to occur. These results demonstrate that PSK interacts with microtubules and affects their organization and stability independently of PSK kinase activity.
无菌20(STE20)蛋白激酶,包括生发中心激酶和p21激活的蛋白激酶,已知可激活丝裂原活化蛋白激酶途径(c-Jun氨基末端激酶、p38或细胞外信号调节激酶),从而导致基因转录的变化。一些STE20s还可调节细胞骨架,并且我们已经表明,生发中心激酶样激酶前列腺衍生的STE20样激酶(PSK)会影响肌动蛋白细胞骨架的组织。在这里,我们证明PSK与微管共定位;并且这种定位会被微管解聚剂诺考达唑破坏。PSK与微管的结合导致产生稳定的核周微管束,这些微管束对诺考达唑具有抗性,并且含有增加水平的乙酰化α-微管蛋白。激酶缺陷型PSK(K57A)或缺乏激酶结构域的PSK的C末端(氨基酸745-1235)足以进行微管结合和稳定,这表明该蛋白的催化活性不是必需的。PSK定位于微管是通过其C末端发生的,并且PSK在体外结合并磷酸化α-和β-微管蛋白。PSK的N末端(1-940)无法结合或稳定微管,这表明PSK必须与微管结合才能发生其重组。这些结果表明,PSK与微管相互作用并独立于PSK激酶活性影响其组织和稳定性。